ANDA Submissions – Amendments and Requests for Final Approval to Tentatively Approved ANDAs: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
January 24, 2024
January 24, 2024
eac298b4-7442-4924-b433-f71c0be0a2f6
Related Documents
Controlled Correspondence Related to Generic Drug Development
Guidance DocumentMarch 18, 2024Center for Drug Evaluation and Research
Good ANDA Submission Practices Guidance for Industry
Guidance DocumentJanuary 26, 2022Center for Drug Evaluation and Research
ANDA Submissions | Amendments to Abbreviated New Drug Applications Under GDUFA: Guidance for Industry
Guidance DocumentSeptember 11, 2024Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox